Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
T-Cell Therapy Market by Modality (Commercialized, Research), Therapy Type (CAR T-cell Therapy, T Cell Receptor-Based, Tumor Infiltrating Lymphocytes-Based), Indication - Global Forecast 2024-2030
... 2023 and expected to reach USD 9.85 billion in 2024, at a CAGR 21.23% to reach USD 31.30 billion by 2030. Global T-Cell Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Human Organoids Market by Product (Colorectal, Heart, Kidney), Usability (Customizable Products, Ready to Use Products), Application, End-Users - Global Forecast 2024-2030
... expected to reach USD 703.34 million in 2024, at a CAGR 19.94% to reach USD 2,124.91 million by 2030. Global Human Organoids Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The Middle East & Africa cell and gene therapy manufacturing services market is expected to ... Read More
-
South & Central America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)
... Tumors) The South & Central America T cell therapy market was valued at US$ 84.11 million in 2022 and is expected to reach US$ 265.59 million by 2030; it is estimated to grow at a ... Read More
-
North America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)
... North America T cell therapy market was valued at US$ 1,645.52 million in 2022 and is expected to reach US$ 5,329.75 million by 2030; it is estimated to grow at a CAGR of 15.8% from ... Read More
-
Asia Pacific Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The Asia Pacific cell and gene therapy manufacturing services market is expected to grow from US$ 1,007.42 ... Read More
-
Acute Lymphoblastic Leukemia Treatment Market (ALL) by Types of Cell (B-cell ALL, Philadelphia chromosome: Positive (Ph+) and negative (Ph-), T-cell ALL), Therapy (Chemotherapy, Radiation Therapy, Stem Cell Transplantation), End-User - Global Forecast 202
... Lymphoblastic Leukemia Treatment Market size was estimated at USD 3.22 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 6.45% to reach USD 4.99 billion by 2030. FPNV Positioning ... Read More
-
Advanced Therapy Medicinal Products CDMO Market by Products (Cell Therapy, Gene Therapy, Tissue Engineered), Phase (Phase I, Phase II, Phase III), Indication, End-Users - Global Forecast 2024-2030
... was estimated at USD 7.54 billion in 2023 and expected to reach USD 8.74 billion in 2024, at a CAGR 17.06% to reach USD 22.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Thalassemia Treatment Market by Type (Blood Transfusion, Bone Marrow & Stem Cell Transplant, Iron Chelation), Indication Type (Alpha Thalassemia, Beta Thalassemia), End-Users - Global Forecast 2024-2030
... 6.38 billion in 2023 and expected to reach USD 7.06 billion in 2024, at a CAGR 12.31% to reach USD 14.38 billion by 2030. Global Thalassemia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Transcutaneous Electrical Nerve Stimulation Market by Surgery Procedures (Direct Nerve Repair, Nerve Grafting, Stem Cell Therapy), Product (Desktop, Portable), End User - Global Forecast 2024-2030
... USD 336.69 million in 2023 and expected to reach USD 348.82 million in 2024, at a CAGR 3.69% to reach USD 434.08 million by 2030. Global Transcutaneous Electrical Nerve Stimulation Market FPNV Positioning Matrix The ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 24.01 billion in 2023 and expected to reach USD 28.82 billion in 2024, at a CAGR 20.13% to reach USD 86.73 billion by 2030. Global Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Cell Banking, Diagnostics) - Global Forecast 2024-2030
... 33.05 billion in 2024, at a CAGR 15.36% to reach USD 77.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment ... Read More
-
Stem Cells Market by Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells), Type (Allogeneic Stem Cell Therapy, Autologous), Therapeutic Application - Global Forecast 2024-
... Market size was estimated at USD 237.23 million in 2023 and expected to reach USD 277.13 million in 2024, at a CAGR 16.91% to reach USD 708.40 million by 2030. Global Stem Cells Market FPNV ... Read More
-
Cell Banking Outsourcing Market by Type (Master Cell Banking, Viral Cell Banking, Working Cell Banking), Cell Type (Non-Stem Cell, Stem Cell), Phase - Global Forecast 2024-2030
... USD 12.64 billion in 2023 and expected to reach USD 14.57 billion in 2024, at a CAGR 15.59% to reach USD 34.87 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Rat & Mouse Model Market by Model Type (Conditioned or Surgically Modified Rats, Genetically Modified Rats, Hybrid or Congenic Rats), Technology (CRISPR, Embryonic Stem Cell Injection, Microinjection), Care Product, Service, Therapeutic Area, End-User - G
... Forecast 2024-2030 The Rat & Mouse Model Market size was estimated at USD 2.26 billion in 2023 and expected to reach USD 2.37 billion in 2024, at a CAGR 5.41% to reach USD 3.27 billion ... Read More
-
Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Global Forecast 2024-2030
... USD 10.70 billion in 2023 and expected to reach USD 12.09 billion in 2024, at a CAGR 13.54% to reach USD 26.03 billion by 2030. Global Upstream Bioprocessing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Umbilical Cord Blood Processing Products Market by Product (CD Markers, Cell Culture Devices, Cell Culture Reagents), End-Users (Private Banks, Public Banks) - Global Forecast 2024-2030
... at USD 1.53 billion in 2023 and expected to reach USD 1.69 billion in 2024, at a CAGR 10.93% to reach USD 3.16 billion by 2030. Global Umbilical Cord Blood Processing Products Market FPNV Positioning ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Global Microcarriers MarketMicrocarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide ... Read More
-
Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Global Forecast 2024-2030
... Based Therapies Market size was estimated at USD 7.17 billion in 2023 and expected to reach USD 8.22 billion in 2024, at a CAGR 14.78% to reach USD 18.83 billion by 2030. FPNV Positioning Matrix ... Read More
-
Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Global Forecast 2024-2030
... size was estimated at USD 9.31 billion in 2023 and expected to reach USD 9.98 billion in 2024, at a CAGR 7.48% to reach USD 15.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Diagnostic Test (Bone Marrow Examination, Complete Blood Count Test, Flow Cytometry), Treatment (Blood Transfusion, Medication, Stem Cell Transplant) - Global Forecast 2024-2030
... estimated at USD 87.89 billion in 2023 and expected to reach USD 103.05 billion in 2024, at a CAGR 17.35% to reach USD 269.37 billion by 2030. Global Partner Relationship Management Market FPNV Positioning Matrix ... Read More
-
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Indication (B-Cell Malignancies, Liver Cancer, Prostate Cancer), Technology Type, End-Use - Global Forecast 2024-2030
... at USD 11.23 billion in 2023 and expected to reach USD 14.02 billion in 2024, at a CAGR 25.34% to reach USD 54.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Stem Cell Therapy Market by Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell Source (Adipose Tissue-Derived MSCs, Bone Marrow-Derived MSCs, Placental / Umbilical Cord-Derived MSCs), Therapeutic Application, End-User - Global Forecas
... Stem Cell Therapy Market size was estimated at USD 439.83 million in 2023 and expected to reach USD 493.20 million in 2024, at a CAGR 12.88% to reach USD 1,027.29 million by 2030. Global Stem ... Read More
-
North America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The North America cell and gene therapy manufacturing services market is expected to grow from US$ 4,153.27 ... Read More
-
South & Central America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The South & Central America cell and gene therapy manufacturing services market is expected to ... Read More
Research Assistance
